cGPS® (cellular Genome Positioning System) Custom technology based on meganuclease-driven homologous recombination for targeted integration in native cell lines. Enables the effortless generation of stable HepG2 isogenic clones in 36 days. Ideal for robust gene functional studies and data comparisons and for the generation of cell-based assays from laboratory's proprietary derived HepG2 clones. Can be applied to any human derived cell line.

• Selection of clones in 36 days
• 85% of targeted integration events
• stable expression >10 weeks even in the absence of selection agents

Integration matrix containing a reporter gene used a positive control for targeted integration. Compatible with any human cell line containing the hsRAG1 gene.

Integration matrix containing a reporter gene used a positive control for targeted integration. Compatible with any human cell line containing the hsRAG1 gene.

Integration matrix where you gene of interest will be cloned. Compatible with any cGPS Cell Line containing the LP2 targeted integration site.